# Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer

> **NCT06407401** · PHASE3 · NOT_YET_RECRUITING · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 399 (estimated)

## Conditions studied

- ER+ Breast Cancer
- HER2-negative Breast Cancer
- Breast Cancer Stage I
- Breast Cancer Stage II
- Breast Cancer Stage III
- Drug-Related Side Effects and Adverse Reactions
- Musculoskeletal Pain

## Interventions

- **DRUG:** Duloxetine 60 MG
- **DRUG:** Furosemide 40 mg
- **BEHAVIORAL:** Booklet for healthy behaviors

## Key facts

- **NCT ID:** NCT06407401
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2028-04-18
- **Final completion:** 2028-11-30
- **Target enrollment:** 399 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06407401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06407401, "Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy - Related Symptoms in Patients With Early Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06407401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*